Exploring the economic and social value of vaccinations
Vaccinations are one of the most effective public health interventions, but what evidence is there of their economic and social value? Is there really a return on investment and what are the interlinks with health, work and prosperity? In this episode, Matthew Taylor put these questions, and more, to Lotte Steuten, deputy chief executive of the Office of Health Economics and Chris Thomas, head of the Health and Prosperity Commission at the IPPR, whose organisations have delved into the detail of these issues.
Tune in for insights on the ROI to the economy and health service, implications on elective recovery, the impact of in-work sickness and lessons from the COVID-19 pandemic.
Advisory note: A number of licenses have now been granted for vaccinations and immunisations against respiratory syncytial virus (RSV) in the UK.
Related reading
- Strengthening the social contract of vaccination
- Steve Russell: Vaccination should be more present in national discourse
- Health inequalities: what the vaccination programme is teaching us
Like what you heard?
Subscribe to get new episodes on Acast, Apple Podcasts, Google Podcasts and Spotify. You can also listen on YouTube.
Health on the Line
Our podcast offers fresh perspectives on the healthcare challenges of our time and ways to confront them. Tune in for interviews with the movers and shakers making waves across health and care.
